Association of Life’s Crucial 9 Score With Liver Fibrosis and Mortality in U.S. Adults With MASLD: Evidence From NHANES and the Mediating Role of Systemic Inflammation
Mediators of Inflammation · 2026-01 · 2026 (1)
DOI: 10.1155/mi/2700500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, online erschienen am 19.06.2026. Verfasst von Zhuo Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China, seu.edu.cn. Hauptthemen laut MEDLINE: Liver Cirrhosis, Inflammation, Fatty Liver. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Development Fund of the Affiliated Hospital of Xuzhou Medical University.
Abstract (Originalsprache)
Background
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is increasingly prevalent. Life’s Crucial 9 (LC9) combines cardiometabolic and mental health metrics linked to MASLD pathogenesis, but its association with liver fibrosis and prognosis in MASLD remains unknown.
Methods
Using National Health and Nutrition Examination Survey (NHANES) data, we performed a prospective cohort analysis for mortality (2005–2016, n = 2524) and a cross‐sectional analysis for liver fibrosis (2017–2018, n = 1277). Significant fibrosis was defined as liver stiffness measurement (LSM) ≥8.0 kPa by vibration‐controlled transient elastography. Systemic inflammation was assessed using the systemic immune‐inflammation index (SII) and pan‐immune‐inflammation value (PIV). Multivariable regression and mediation analyses were conducted.
Results
Higher LC9 scores were associated with lower liver stiffness ( β = −0.07, 95% CI: −0.12 to −0.01). Each 1‐point increase in LC9 reduced fibrosis risk by 5% (OR = 0.95), with the highest quartile showing the lowest risk (OR = 0.21). Over a median follow‐up of 98 months, each 1‐point LC9 increase was associated with a 3% reduction in all‐cause mortality (HR = 0.97). Lower systemic inflammation partially mediated the LC9‐mortality relationship (SII: 5%, PIV: 6.3%).
Conclusion
Higher LC9 scores are associated with reduced liver fibrosis and improved survival in MASLD, with systemic inflammation partially mediating the mortality association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China, seu.edu.cn.
- Department of Neurology, Xuzhou Central Hospital, Southeast University, Xuzhou, Jiangsu, China, seu.edu.cn.
Förderung
- Development Fund of the Affiliated Hospital of Xuzhou Medical University
Zitieren
APA
Chen, Z., Shi, L., Lu, J., & Su, J. (2026). Association of Life’s Crucial 9 Score With Liver Fibrosis and Mortality in U.S. Adults With MASLD: Evidence From NHANES and the Mediating Role of Systemic Inflammation. Mediators of Inflammation, 2026(1). https://doi.org/10.1155/mi/2700500
Vancouver
Chen Z, Shi L, Lu J, Su J. Association of Life’s Crucial 9 Score With Liver Fibrosis and Mortality in U.S. Adults With MASLD: Evidence From NHANES and the Mediating Role of Systemic Inflammation. Mediators of Inflammation. 2026;2026(1). doi:10.1155/mi/2700500
BibTeX
@article{Chen2026,
author = {Chen, Zhuo and Shi, Lin and Lu, Junjie and Su, Jing},
title = {Association of Life’s Crucial 9 Score With Liver Fibrosis and Mortality in U.S. Adults With MASLD: Evidence From NHANES and the Mediating Role of Systemic Inflammation},
journal = {Mediators of Inflammation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/mi/2700500}
}
EUVIMED